Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 170 entries
Sorted by: Best Match Show Resources per page
Functional activity of peripheral blood eosinophils in allergen-induced late-phase airway inflammation in asthma patients.

Journal of inflammation (London, England)

Lavinskiene S, Malakauskas K, Jeroch J, Hoppenot D, Sakalauskas R.
PMID: 25829869
J Inflamm (Lond). 2015 Mar 29;12:25. doi: 10.1186/s12950-015-0065-4. eCollection 2015.

OBJECTIVE: We aimed to investigate peripheral blood eosinophil chemotaxis, generation of spontaneous reactive oxygen species (ROS), and apoptosis in patients with allergic asthma after bronchial allergen challenge.MATERIAL AND METHODS: A total of 18 patients with allergic asthma (AA), 14...

Cite
Lavinskiene S, Malakauskas K, Jeroch J, et al. Functional activity of peripheral blood eosinophils in allergen-induced late-phase airway inflammation in asthma patients. J Inflamm (Lond). 2015;12:25doi: 10.1186/s12950-015-0065-4.
Lavinskiene, S., Malakauskas, K., Jeroch, J., Hoppenot, D., & Sakalauskas, R. (2015). Functional activity of peripheral blood eosinophils in allergen-induced late-phase airway inflammation in asthma patients. Journal of inflammation (London, England), 1225. https://doi.org/10.1186/s12950-015-0065-4
Lavinskiene, Simona, et al. "Functional activity of peripheral blood eosinophils in allergen-induced late-phase airway inflammation in asthma patients." Journal of inflammation (London, England) vol. 12 (2015): 25. doi: https://doi.org/10.1186/s12950-015-0065-4
Lavinskiene S, Malakauskas K, Jeroch J, Hoppenot D, Sakalauskas R. Functional activity of peripheral blood eosinophils in allergen-induced late-phase airway inflammation in asthma patients. J Inflamm (Lond). 2015 Mar 29;12:25. doi: 10.1186/s12950-015-0065-4. eCollection 2015. PMID: 25829869; PMCID: PMC4379944.
Copy Download .nbib Format: NLM
New critical-state model for critical currents in ceramic high-Tc superconductors.

Physical review. B, Condensed matter

Blatter G, Dersch H.
PMID: 9946020
Phys Rev B Condens Matter. 1988 Dec 01;38(16):11391-11404. doi: 10.1103/physrevb.38.11391.

No abstract available.

Cite
Blatter G, Dersch H. New critical-state model for critical currents in ceramic high-Tc superconductors. Phys Rev B Condens Matter. 1988;38(16):11391-11404doi: 10.1103/physrevb.38.11391.
Blatter, G., & Dersch, H. (1988). New critical-state model for critical currents in ceramic high-Tc superconductors. Physical review. B, Condensed matter, 38(16), 11391-11404. https://doi.org/10.1103/physrevb.38.11391
Blatter, and Dersch. "New critical-state model for critical currents in ceramic high-Tc superconductors." Physical review. B, Condensed matter vol. 38,16 (1988): 11391-11404. doi: https://doi.org/10.1103/physrevb.38.11391
Blatter G, Dersch H. New critical-state model for critical currents in ceramic high-Tc superconductors. Phys Rev B Condens Matter. 1988 Dec 01;38(16):11391-11404. doi: 10.1103/physrevb.38.11391. PMID: 9946020.
Copy Download .nbib Format: NLM
Regional Delivery of CAR-T Effectively Controls Tumor Growth in Colorectal Liver Metastasis Model.

The Journal of surgical research

Chai LF, Hardaway JC, Heatherton KR, O'Connell KP, LaPorte JP, Guha P, Lopes MC, Rabinowitz BA, Jaroch D, Cox BF, Knight R, Katz SC.
PMID: 34929499
J Surg Res. 2021 Dec 17;272:37-50. doi: 10.1016/j.jss.2021.11.001. Epub 2021 Dec 17.

BACKGROUND: Effective treatment of solid tumors requires multi-modality approaches. In many patients with stage IV liver disease, current treatments are not curative. Chimeric antigen receptor T cells (CAR-T) are an intriguing option following success in hematological malignancies, but this...

Cite
Chai LF, Hardaway JC, Heatherton KR, et al. Regional Delivery of CAR-T Effectively Controls Tumor Growth in Colorectal Liver Metastasis Model. J Surg Res. 2021;272:37-50doi: 10.1016/j.jss.2021.11.001.
Chai, L. F., Hardaway, J. C., Heatherton, K. R., O'Connell, K. P., LaPorte, J. P., Guha, P., Lopes, M. C., Rabinowitz, B. A., Jaroch, D., Cox, B. F., Knight, R., & Katz, S. C. (2021). Regional Delivery of CAR-T Effectively Controls Tumor Growth in Colorectal Liver Metastasis Model. The Journal of surgical research, 27237-50. https://doi.org/10.1016/j.jss.2021.11.001
Chai, Louis F, et al. "Regional Delivery of CAR-T Effectively Controls Tumor Growth in Colorectal Liver Metastasis Model." The Journal of surgical research vol. 272 (2021): 37-50. doi: https://doi.org/10.1016/j.jss.2021.11.001
Chai LF, Hardaway JC, Heatherton KR, O'Connell KP, LaPorte JP, Guha P, Lopes MC, Rabinowitz BA, Jaroch D, Cox BF, Knight R, Katz SC. Regional Delivery of CAR-T Effectively Controls Tumor Growth in Colorectal Liver Metastasis Model. J Surg Res. 2021 Dec 17;272:37-50. doi: 10.1016/j.jss.2021.11.001. Epub 2021 Dec 17. PMID: 34929499.
Copy Download .nbib Format: NLM
Safety and Efficacy of Pembrolizumab in Combination With Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study.

Clinical cancer research : an official journal of the American Association for Cancer Research

Taylor MH, Betts CB, Maloney L, Nadler E, Algazi A, Guarino MJ, Nemunaitis J, Jimeno A, Patel P, Munugalavadla V, Tao L, Adkins D, Goldschmidt JH, Cohen EEW, Coussens LM.
PMID: 34862248
Clin Cancer Res. 2021 Dec 03; doi: 10.1158/1078-0432.CCR-21-2547. Epub 2021 Dec 03.

PURPOSE: Programmed cell death-1 (PD-1) receptor inhibitors have shown efficacy in head and neck squamous cell carcinoma (HNSCC), but treatment failure or secondary resistance occurs in most patients. In preclinical murine carcinoma models, inhibition of Bruton's tyrosine kinase (BTK)...

Cite
Taylor MH, Betts CB, Maloney L, et al. Safety and Efficacy of Pembrolizumab in Combination With Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study. Clin Cancer Res. 2021;doi: 10.1158/1078-0432.CCR-21-2547.
Taylor, M. H., Betts, C. B., Maloney, L., Nadler, E., Algazi, A., Guarino, M. J., Nemunaitis, J., Jimeno, A., Patel, P., Munugalavadla, V., Tao, L., Adkins, D., Goldschmidt, J. H., Cohen, E. E. W., & Coussens, L. M. (2021). Safety and Efficacy of Pembrolizumab in Combination With Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study. Clinical cancer research : an official journal of the American Association for Cancer Research, . https://doi.org/10.1158/1078-0432.CCR-21-2547
Taylor, Matthew H, et al. "Safety and Efficacy of Pembrolizumab in Combination With Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study." Clinical cancer research : an official journal of the American Association for Cancer Research vol. (2021). doi: https://doi.org/10.1158/1078-0432.CCR-21-2547
Taylor MH, Betts CB, Maloney L, Nadler E, Algazi A, Guarino MJ, Nemunaitis J, Jimeno A, Patel P, Munugalavadla V, Tao L, Adkins D, Goldschmidt JH, Cohen EEW, Coussens LM. Safety and Efficacy of Pembrolizumab in Combination With Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study. Clin Cancer Res. 2021 Dec 03; doi: 10.1158/1078-0432.CCR-21-2547. Epub 2021 Dec 03. PMID: 34862248.
Copy Download .nbib Format: NLM
Correction to: Racial Implicit Associations in Psychiatric Diagnosis, Treatment, and Compliance Expectations.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry

Londono Tobon A, Flores JM, Taylor JH, Johnson I, Landeros-Weisenberger A, Aboiralor O, Avila-Quintero VJ, Bloch MH.
PMID: 33821450
Acad Psychiatry. 2021 Aug;45(4):533-534. doi: 10.1007/s40596-021-01435-w.

No abstract available.

Cite
Londono Tobon A, Flores JM, Taylor JH, et al. Correction to: Racial Implicit Associations in Psychiatric Diagnosis, Treatment, and Compliance Expectations. Acad Psychiatry. 2021;45(4):533-534doi: 10.1007/s40596-021-01435-w.
Londono Tobon, A., Flores, J. M., Taylor, J. H., Johnson, I., Landeros-Weisenberger, A., Aboiralor, O., Avila-Quintero, V. J., & Bloch, M. H. (2021). Correction to: Racial Implicit Associations in Psychiatric Diagnosis, Treatment, and Compliance Expectations. Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry, 45(4), 533-534. https://doi.org/10.1007/s40596-021-01435-w
Londono Tobon, Amalia, et al. "Correction to: Racial Implicit Associations in Psychiatric Diagnosis, Treatment, and Compliance Expectations." Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry vol. 45,4 (2021): 533-534. doi: https://doi.org/10.1007/s40596-021-01435-w
Londono Tobon A, Flores JM, Taylor JH, Johnson I, Landeros-Weisenberger A, Aboiralor O, Avila-Quintero VJ, Bloch MH. Correction to: Racial Implicit Associations in Psychiatric Diagnosis, Treatment, and Compliance Expectations. Acad Psychiatry. 2021 Aug;45(4):533-534. doi: 10.1007/s40596-021-01435-w. PMID: 33821450.
Copy Download .nbib Format: NLM
Regional Delivery of CAR-T Effectively Controls Tumor Growth in Colorectal Liver Metastasis Model.

The Journal of surgical research

Chai LF, Hardaway JC, Heatherton KR, O'Connell KP, LaPorte JP, Guha P, Lopes MC, Rabinowitz BA, Jaroch D, Cox BF, Knight R, Katz SC.
PMID: 34929499
J Surg Res. 2021 Dec 17;272:37-50. doi: 10.1016/j.jss.2021.11.001. Epub 2021 Dec 17.

BACKGROUND: Effective treatment of solid tumors requires multi-modality approaches. In many patients with stage IV liver disease, current treatments are not curative. Chimeric antigen receptor T cells (CAR-T) are an intriguing option following success in hematological malignancies, but this...

Cite
Chai LF, Hardaway JC, Heatherton KR, et al. Regional Delivery of CAR-T Effectively Controls Tumor Growth in Colorectal Liver Metastasis Model. J Surg Res. 2021;272:37-50doi: 10.1016/j.jss.2021.11.001.
Chai, L. F., Hardaway, J. C., Heatherton, K. R., O'Connell, K. P., LaPorte, J. P., Guha, P., Lopes, M. C., Rabinowitz, B. A., Jaroch, D., Cox, B. F., Knight, R., & Katz, S. C. (2021). Regional Delivery of CAR-T Effectively Controls Tumor Growth in Colorectal Liver Metastasis Model. The Journal of surgical research, 27237-50. https://doi.org/10.1016/j.jss.2021.11.001
Chai, Louis F, et al. "Regional Delivery of CAR-T Effectively Controls Tumor Growth in Colorectal Liver Metastasis Model." The Journal of surgical research vol. 272 (2021): 37-50. doi: https://doi.org/10.1016/j.jss.2021.11.001
Chai LF, Hardaway JC, Heatherton KR, O'Connell KP, LaPorte JP, Guha P, Lopes MC, Rabinowitz BA, Jaroch D, Cox BF, Knight R, Katz SC. Regional Delivery of CAR-T Effectively Controls Tumor Growth in Colorectal Liver Metastasis Model. J Surg Res. 2021 Dec 17;272:37-50. doi: 10.1016/j.jss.2021.11.001. Epub 2021 Dec 17. PMID: 34929499.
Copy Download .nbib Format: NLM
Synthesis of Novel Polymeric Acrylate-Based Flame Retardants Containing Two Phosphorus Groups in Different Chemical Environments and Their Influence on the Flammability of Poly (Lactic Acid).

Polymers

Sag J, Kukla P, Goedderz D, Roch H, Kabasci S, Döring M, Schönberger F.
PMID: 32244836
Polymers (Basel). 2020 Apr 01;12(4). doi: 10.3390/polym12040778.

Novel polymeric acrylate-based flame retardants (FR 1-4) containing two phosphorus groups in different chemical environments were synthesized in three steps and characterized via nuclear magnetic resonance (NMR) spectroscopy, thermogravimetric analysis (TGA), differential scanning calorimetry (DSC), and mass spectrometry (MS)....

Cite
Sag J, Kukla P, Goedderz D, et al. Synthesis of Novel Polymeric Acrylate-Based Flame Retardants Containing Two Phosphorus Groups in Different Chemical Environments and Their Influence on the Flammability of Poly (Lactic Acid). Polymers (Basel). 2020;12(4)doi: 10.3390/polym12040778.
Sag, J., Kukla, P., Goedderz, D., Roch, H., Kabasci, S., Döring, M., & Schönberger, F. (2020). Synthesis of Novel Polymeric Acrylate-Based Flame Retardants Containing Two Phosphorus Groups in Different Chemical Environments and Their Influence on the Flammability of Poly (Lactic Acid). Polymers, 12(4), . https://doi.org/10.3390/polym12040778
Sag, Jacob, et al. "Synthesis of Novel Polymeric Acrylate-Based Flame Retardants Containing Two Phosphorus Groups in Different Chemical Environments and Their Influence on the Flammability of Poly (Lactic Acid)." Polymers vol. 12,4 (2020). doi: https://doi.org/10.3390/polym12040778
Sag J, Kukla P, Goedderz D, Roch H, Kabasci S, Döring M, Schönberger F. Synthesis of Novel Polymeric Acrylate-Based Flame Retardants Containing Two Phosphorus Groups in Different Chemical Environments and Their Influence on the Flammability of Poly (Lactic Acid). Polymers (Basel). 2020 Apr 01;12(4). doi: 10.3390/polym12040778. PMID: 32244836; PMCID: PMC7240360.
Copy Download .nbib Format: NLM
Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients.

NPJ breast cancer

Paul D, Vukelja SJ, Ann Holmes F, Blum JL, McIntyre KJ, Lindquist DL, Osborne CR, Sanchez IJ, Goldschmidt JH, Wang Y, Asmar L, Strauss L, O'Shaughnessy J.
PMID: 31667338
NPJ Breast Cancer. 2019 Oct 28;5:36. doi: 10.1038/s41523-019-0132-8. eCollection 2019.

The non-receptor tyrosine kinase Src activation plays a role in the malignant progression of breast cancer, including development of endocrine therapy resistance and survival of bone metastases. This study investigated whether adding Src kinase inhibitor dasatinib to aromatase inhibitor...

Cite
Paul D, Vukelja SJ, Ann Holmes F, et al. Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients. NPJ Breast Cancer. 2019;5:36doi: 10.1038/s41523-019-0132-8.
Paul, D., Vukelja, S. J., Ann Holmes, F., Blum, J. L., McIntyre, K. J., Lindquist, D. L., Osborne, C. R., Sanchez, I. J., Goldschmidt, J. H., Wang, Y., Asmar, L., Strauss, L., & O'Shaughnessy, J. (2019). Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients. NPJ breast cancer, 536. https://doi.org/10.1038/s41523-019-0132-8
Paul, Devchand, et al. "Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients." NPJ breast cancer vol. 5 (2019): 36. doi: https://doi.org/10.1038/s41523-019-0132-8
Paul D, Vukelja SJ, Ann Holmes F, Blum JL, McIntyre KJ, Lindquist DL, Osborne CR, Sanchez IJ, Goldschmidt JH, Wang Y, Asmar L, Strauss L, O'Shaughnessy J. Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients. NPJ Breast Cancer. 2019 Oct 28;5:36. doi: 10.1038/s41523-019-0132-8. eCollection 2019. PMID: 31667338; PMCID: PMC6817898.
Copy Download .nbib Format: NLM
Limited Treatment Options in Primary Hyperoxaluria with Renal Failure.

Case reports in nephrology and dialysis

Geiger K, Mroch H.
PMID: 33173783
Case Rep Nephrol Dial. 2020 Oct 05;10(3):104-108. doi: 10.1159/000510143. eCollection 2020.

Primary hyperoxaluria (PH) is a rare autosomal recessive metabolic disorder where serum oxalate levels rise due to overproduction. The kidney tubule is a main target for oxalate deposition, resulting in damage to the organ. Kidney failure is rare in...

Cite
Geiger K, Mroch H. Limited Treatment Options in Primary Hyperoxaluria with Renal Failure. Case Rep Nephrol Dial. 2020;10(3):104-108doi: 10.1159/000510143.
Geiger, K., & Mroch, H. (2020). Limited Treatment Options in Primary Hyperoxaluria with Renal Failure. Case reports in nephrology and dialysis, 10(3), 104-108. https://doi.org/10.1159/000510143
Geiger, Kyle, and Mroch, Henry. "Limited Treatment Options in Primary Hyperoxaluria with Renal Failure." Case reports in nephrology and dialysis vol. 10,3 (2020): 104-108. doi: https://doi.org/10.1159/000510143
Geiger K, Mroch H. Limited Treatment Options in Primary Hyperoxaluria with Renal Failure. Case Rep Nephrol Dial. 2020 Oct 05;10(3):104-108. doi: 10.1159/000510143. eCollection 2020. PMID: 33173783; PMCID: PMC7588674.
Copy Download .nbib Format: NLM
Self-Assembly Properties of Solution Processable, Electroactive Alkoxy, and Alkylthienylene Derivatives of Fused Benzoacridines: A Scanning Tunneling Microscopy Study.

Langmuir : the ACS journal of surfaces and colloids

Jaroch T, Maranda-Niedbała A, Krzyżewska K, Kotwica K, Bujak P, Skórka Ł, Zagórska M, Proń A, Nowakowski R.
PMID: 32340450
Langmuir. 2020 May 19;36(19):5417-5427. doi: 10.1021/acs.langmuir.9b03966. Epub 2020 May 08.

Self-organization in mono- and bilayers on HOPG of two groups of benz[5,6]acridino[2,1,9,8-

Cite
Jaroch T, Maranda-Niedbała A, Krzyżewska K, et al. Self-Assembly Properties of Solution Processable, Electroactive Alkoxy, and Alkylthienylene Derivatives of Fused Benzoacridines: A Scanning Tunneling Microscopy Study. Langmuir. 2020;36(19):5417-5427doi: 10.1021/acs.langmuir.9b03966.
Jaroch, T., Maranda-Niedbała, A., Krzyżewska, K., Kotwica, K., Bujak, P., Skórka, �. �., Zagórska, M., Proń, A., & Nowakowski, R. (2020). Self-Assembly Properties of Solution Processable, Electroactive Alkoxy, and Alkylthienylene Derivatives of Fused Benzoacridines: A Scanning Tunneling Microscopy Study. Langmuir : the ACS journal of surfaces and colloids, 36(19), 5417-5427. https://doi.org/10.1021/acs.langmuir.9b03966
Jaroch, Tomasz, et al. "Self-Assembly Properties of Solution Processable, Electroactive Alkoxy, and Alkylthienylene Derivatives of Fused Benzoacridines: A Scanning Tunneling Microscopy Study." Langmuir : the ACS journal of surfaces and colloids vol. 36,19 (2020): 5417-5427. doi: https://doi.org/10.1021/acs.langmuir.9b03966
Jaroch T, Maranda-Niedbała A, Krzyżewska K, Kotwica K, Bujak P, Skórka Ł, Zagórska M, Proń A, Nowakowski R. Self-Assembly Properties of Solution Processable, Electroactive Alkoxy, and Alkylthienylene Derivatives of Fused Benzoacridines: A Scanning Tunneling Microscopy Study. Langmuir. 2020 May 19;36(19):5417-5427. doi: 10.1021/acs.langmuir.9b03966. Epub 2020 May 08. PMID: 32340450; PMCID: PMC7588136.
Copy Download .nbib Format: NLM
Severe headache as the sole presenting symptom of COVID-19 pneumonia: A case report.

Interdisciplinary neurosurgery : Advanced techniques and case management

Kimambo H, Chin JH, Mnacho M, Punatar P, Msilanga D, Chagula AC.
PMID: 32835023
Interdiscip Neurosurg. 2020 Dec;22:100882. doi: 10.1016/j.inat.2020.100882. Epub 2020 Aug 13.

The spectrum of symptoms of COVID-19 continues to expand as more clinical observations are reported. Neurological manifestations including headache are increasingly described. However, headache as the sole presenting symptom of COVID-19 pneumonia has not been reported. We describe a...

Cite
Kimambo H, Chin JH, Mnacho M, et al. Severe headache as the sole presenting symptom of COVID-19 pneumonia: A case report. Interdiscip Neurosurg. 2020;22:100882doi: 10.1016/j.inat.2020.100882.
Kimambo, H., Chin, J. H., Mnacho, M., Punatar, P., Msilanga, D., & Chagula, A. C. (2020). Severe headache as the sole presenting symptom of COVID-19 pneumonia: A case report. Interdisciplinary neurosurgery : Advanced techniques and case management, 22100882. https://doi.org/10.1016/j.inat.2020.100882
Kimambo, Henrika, et al. "Severe headache as the sole presenting symptom of COVID-19 pneumonia: A case report." Interdisciplinary neurosurgery : Advanced techniques and case management vol. 22 (2020): 100882. doi: https://doi.org/10.1016/j.inat.2020.100882
Kimambo H, Chin JH, Mnacho M, Punatar P, Msilanga D, Chagula AC. Severe headache as the sole presenting symptom of COVID-19 pneumonia: A case report. Interdiscip Neurosurg. 2020 Dec;22:100882. doi: 10.1016/j.inat.2020.100882. Epub 2020 Aug 13. PMID: 32835023; PMCID: PMC7423632.
Copy Download .nbib Format: NLM
Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.

The Lancet. Infectious diseases

Kumar Rai G, Saluja T, Chaudhary S, Tamrakar D, Kanodia P, Giri BR, Shrestha R, Uranw S, Kim DR, Yang JS, Park IY, Kyung SE, Vemula S, Reddy E J, Kim B, Gupta BP, Jo SK, Ryu JH, Park HK, Shin JH, Lee Y, Kim H, Kim JH, Mojares ZR, Wartel TA, Sahastrabuddhe S.
PMID: 34942090
Lancet Infect Dis. 2021 Dec 20; doi: 10.1016/S1473-3099(21)00455-2. Epub 2021 Dec 20.

BACKGROUND: Typhoid fever is an endemic disease in many low-income and middle-income countries. The 2018 WHO position paper recommends that countries should consider typhoid vaccination in high-risk groups and for outbreak control. To address the typhoid vaccine supply and...

Cite
Kumar Rai G, Saluja T, Chaudhary S, et al. Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial. Lancet Infect Dis. 2021;doi: 10.1016/S1473-3099(21)00455-2.
Kumar Rai, G., Saluja, T., Chaudhary, S., Tamrakar, D., Kanodia, P., Giri, B. R., Shrestha, R., Uranw, S., Kim, D. R., Yang, J. S., Park, I. Y., Kyung, S. E., Vemula, S., Reddy E, J., Kim, B., Gupta, B. P., Jo, S. K., Ryu, J. H., Park, H. K., Shin, J. H., Lee, Y., Kim, H., Kim, J. H., Mojares, Z. R., Wartel, T. A., & Sahastrabuddhe, S. (2021). Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial. The Lancet. Infectious diseases, . https://doi.org/10.1016/S1473-3099(21)00455-2
Kumar Rai, Ganesh, et al. "Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial." The Lancet. Infectious diseases vol. (2021). doi: https://doi.org/10.1016/S1473-3099(21)00455-2
Kumar Rai G, Saluja T, Chaudhary S, Tamrakar D, Kanodia P, Giri BR, Shrestha R, Uranw S, Kim DR, Yang JS, Park IY, Kyung SE, Vemula S, Reddy E J, Kim B, Gupta BP, Jo SK, Ryu JH, Park HK, Shin JH, Lee Y, Kim H, Kim JH, Mojares ZR, Wartel TA, Sahastrabuddhe S. Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial. Lancet Infect Dis. 2021 Dec 20; doi: 10.1016/S1473-3099(21)00455-2. Epub 2021 Dec 20. PMID: 34942090.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 170 entries